News Image

Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary

Provided By GlobeNewswire

Last update: Jun 24, 2025

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 24, 2025 (GLOBE NEWSWIRE) --  Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced the recent ruling by an Administrative Law Judge (“ALJ”) in favor of an appeal by a Medicare beneficiary that their ReWalk Personal Exoskeleton shall be covered and reimbursed by Medicare as a “reasonable and necessary” medical device that enables walking after spinal cord injury (“SCI”). The ruling establishes a legal basis that the ReWalk system constitutes a reasonable and necessary medical intervention for paralyzed individuals.

Read more at globenewswire.com

LIFEWARD LTD

NASDAQ:LFWD (10/17/2025, 6:28:24 PM)

After market: 0.7279 +0.04 (+5.68%)

0.6888

-0.02 (-3%)



Find more stocks in the Stock Screener

Follow ChartMill for more